NCT05415488

Brief Summary

Irritable bowel syndrome (IBS) is a multifaceted disorder where diet plays a pivotal role in symptom generation and management. The traditional dietary advice given to patients in clinical settings are based on the NICE guidelines. Some of the advice included in these guidelines have limited scientific evidence. The aim of this study is to investigate the effectiveness of the traditional dietary advice in IBS, according to the NICE guidelines, within a primary health care setting, where treatment is delivered digitally and in groups of 8-12 individuals. As a sham comparator, one group will receive dietary advice according to the Swedish dietary guidelines regarding healthy eating habits.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 13, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

August 15, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

December 1, 2023

Status Verified

November 1, 2023

Enrollment Period

2.1 years

First QC Date

June 7, 2022

Last Update Submit

November 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with significant symptom reduction

    A responder to treatment is defined as having a symptom reduction \>50 measured by IBS-SSS

    From baseline vs. 6 weeks after group session

Study Arms (2)

IBS dietary advice according to the NICE guidelines

ACTIVE COMPARATOR

The traditional dietary advice according to the NICE guidelines and the systematic reviews performed by the British dietetic association (BDA) include having regular meals and to take time to eat, not to skip meals or eat too much at ones. The diet also limits intake of known trigger foods, such as coffee, alcohol, fizzy drinks, spicy foods, fatty foods etc. People who experience loose stools are recommended to avoid sweeteners (-ol), and people with wind/bloating are recommended to eat soluble fibers such as oats and flaxseeds.

Other: Online dietary group treatment

A healthy diet according to the Swedish dietary guidelines

SHAM COMPARATOR

This diet includes eating 500 grams of vegetables and fruits/day, fish approximately 3 times/week, 70 grams of wholegrain/day and to limit intake of red meat.

Other: Online dietary group treatment

Interventions

Dietary advice will be given during one 90 minute online group session

A healthy diet according to the Swedish dietary guidelinesIBS dietary advice according to the NICE guidelines

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed with IBS (ROME IV) by physician
  • Age 18-50
  • Ability to read and understand Swedish
  • Signed informed consent

You may not qualify if:

  • Received dietary treatment for IBS previously
  • Manifestations of other conditions that may explain gastrointestinal symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept of Internal Medicine, Sahlgrenska University Hospital

Gothenburg, 41345, Sweden

RECRUITING

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Central Study Contacts

Sanna Nybacka, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will only be told that the both diets aim to relieve symptoms of IBS, and that none of the diets are expected to cure the disorder. No specific names of the diets will be given.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intervention study with 2 parallel arms (1:1)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 7, 2022

First Posted

June 13, 2022

Study Start

August 15, 2022

Primary Completion

September 15, 2024

Study Completion

September 15, 2025

Last Updated

December 1, 2023

Record last verified: 2023-11

Locations